ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Natamycin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-28W2310
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Natamycin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Natamycin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-28W2310
Report
May 2025
Pages:153
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Danisco
DSM
VGP
Handary
Amtech Biotech
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome

Natamycin Market Size

In 2024, the global market size of Natamycin was estimated to be worth US$ 210 million and is forecast to reach approximately US$ 323 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.

Natamycin Market

Natamycin Market

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.
North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.
In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Natamycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natamycin.
The Natamycin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Natamycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natamycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Natamycin Market Report

Report Metric Details
Report Name Natamycin Market
Forecasted market size in 2031 approximately US$ 323 million
CAGR 6.4%
Forecasted years 2025 - 2031
Segment by Type
  • Glucose-based
  • Lactose-based
  • Sodium chloride-based
Segment by Application
  • Food
  • Medical
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Natamycin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Natamycin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Natamycin Market size in 2031?

Ans: The Natamycin Market size in 2031 will be approximately US$ 323 million.

What is the market share of major companies in Natamycin Market?

Ans: Global top five players hold a share about 50%.

Who are the main players in the Natamycin Market report?

Ans: The main players in the Natamycin Market are Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome

What are the Application segmentation covered in the Natamycin Market report?

Ans: The Applications covered in the Natamycin Market report are Food, Medical, Others

What are the Type segmentation covered in the Natamycin Market report?

Ans: The Types covered in the Natamycin Market report are Glucose-based, Lactose-based, Sodium chloride-based

Recommended Reports

Antifungal Drugs

Antifungal Solutions

Pharmaceutical Ingredients

Market trends :

Topic Trends
Global rising demand for natural food preservatives and antifungal agents is driving natamycin market growth across food and medical sectors globally.
Type Glucose-based - glucose-based natamycin is gaining traction due to its compatibility with clean-label food formulations.
Lactose-based - lactose-based natamycin remains preferred in dairy preservation applications, supporting its steady market presence.
Sodium chloride-based - sodium chloride-based natamycin is increasingly adopted for processed meat and sausage preservation.
Application Food - food industry adoption of natamycin is accelerating due to consumer preference for natural preservatives in dairy and meat products.
Medical - medical applications of natamycin are expanding as antifungal treatments gain regulatory and clinical acceptance.
Region North America - north america leads natamycin consumption driven by stringent food safety regulations and demand for natural additives.
EMEA - emea region is experiencing steady growth in natamycin use, particularly in european dairy and meat industries.
APAC - apac market for natamycin is expanding rapidly due to increased processed food production and rising health awareness.
LATAM - latam is witnessing growing natamycin adoption in food preservation, supported by local food processing industry expansion.
1 Study Coverage
1.1 Natamycin Product Introduction
1.2 Market by Type
1.2.1 Global Natamycin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Glucose-based
1.2.3 Lactose-based
1.2.4 Sodium chloride-based
1.3 Market by Application
1.3.1 Global Natamycin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Food
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Natamycin Market Size Estimates and Forecasts
2.1.1 Global Natamycin Revenue 2020-2031
2.1.2 Global Natamycin Sales 2020-2031
2.2 Natamycin Market Size by Region: 2024 Versus 2031
2.3 Natamycin Sales by Region (2020-2031)
2.3.1 Global Natamycin Sales by Region: 2020-2025
2.3.2 Global Natamycin Sales Forecast by Region (2026-2031)
2.3.3 Global Natamycin Sales Market Share by Region (2020-2031)
2.4 Natamycin Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Natamycin Revenue by Region: 2020-2025
2.4.2 Global Natamycin Revenue Forecast by Region (2026-2031)
2.4.3 Global Natamycin Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Natamycin Sales by Type (2020-2031)
3.1.1.1 Global Natamycin Sales Volume by Type (2020-2031)
3.1.1.2 Global Natamycin Sales Market Share by Type (2020-2031)
3.1.2 Global Natamycin Revenue by Type (2020-2031)
3.1.2.1 Global Natamycin Revenue by Type (2020-2031)
3.1.2.2 Global Natamycin Revenue Market Share by Type (2020-2031)
3.1.3 Natamycin Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Natamycin Sales by Application (2020-2031)
3.2.1.1 Global Natamycin Sales Volume by Application (2020-2031)
3.2.1.2 Global Natamycin Sales Market Share by Application (2020-2031)
3.2.2 Global Natamycin Revenue by Application (2020-2031)
3.2.2.1 Global Natamycin Revenue by Application (2020-2031)
3.2.2.2 Global Natamycin Revenue Market Share by Application (2020-2031)
3.2.3 Natamycin Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Glucose-based of Natamycin Revenue Market Share by Application
3.3.2 Lactose-based of Natamycin Revenue Market Share by Application
3.3.3 Sodium chloride-based of Natamycin Revenue Market Share by Application
4 Global Natamycin by Manufacturers
4.1 Global Top Natamycin Manufacturers by Sales (2020-2025)
4.1.1 Global Natamycin Sales by Manufacturer (2020-2025)
4.1.2 Global Natamycin Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Natamycin Manufacturers by Revenue (2020-2025)
4.2.1 Global Natamycin Revenue by Manufacturer (2020-2025)
4.2.2 Global Natamycin Revenue Share by Manufacturer (2020-2025)
4.3 Global Natamycin Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Natamycin Manufacturers Covered: Ranking by Revenue
4.4.2 Global Natamycin Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Natamycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Natamycin Manufacturing Base Distribution, Product Type
4.5.1 Natamycin Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Natamycin Market
4.5.3 Manufacturers Natamycin Product Type and Application
4.5.4 Glucose-based Market Sales of Natamycin by Manufacturer
4.5.5 Lactose-based Market Sales of Natamycin by Manufacturer
4.5.6 Sodium chloride-based Market Sales of Natamycin by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Danisco
5.1.1 Danisco Company Information
5.1.2 Danisco Description, Business Overview
5.1.3 Danisco Natamycin Products Offered
5.1.4 Danisco Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Danisco Natamycin Sales by Product in 2024
5.1.6 Danisco Natamycin Sales by Application in 2024
5.1.7 Danisco Natamycin Sales by Geographic Area in 2024
5.1.8 Danisco Recent Developments
5.2 DSM
5.2.1 DSM Company Information
5.2.2 DSM Description, Business Overview
5.2.3 DSM Natamycin Products Offered
5.2.4 DSM Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.2.5 DSM Natamycin Sales by Product in 2024
5.2.6 DSM Natamycin Sales by Application in 2024
5.2.7 DSM Natamycin Sales by Geographic Area in 2024
5.2.8 DSM Recent Developments
5.3 VGP
5.3.1 VGP Company Information
5.3.2 VGP Description, Business Overview
5.3.3 VGP Natamycin Products Offered
5.3.4 VGP Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.3.5 VGP Natamycin Sales by Product in 2024
5.3.6 VGP Natamycin Sales by Application in 2024
5.3.7 VGP Natamycin Sales by Geographic Area in 2024
5.3.8 VGP Recent Developments
5.4 Handary
5.4.1 Handary Company Information
5.4.2 Handary Description, Business Overview
5.4.3 Handary Natamycin Products Offered
5.4.4 Handary Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Handary Natamycin Sales by Product in 2024
5.4.6 Handary Natamycin Sales by Application in 2024
5.4.7 Handary Natamycin Sales by Geographic Area in 2024
5.4.8 Handary Recent Developments
5.5 AMTECH BIOTECH
5.5.1 AMTECH BIOTECH Company Information
5.5.2 AMTECH BIOTECH Description, Business Overview
5.5.3 AMTECH BIOTECH Natamycin Products Offered
5.5.4 AMTECH BIOTECH Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.5.5 AMTECH BIOTECH Natamycin Sales by Product in 2024
5.5.6 AMTECH BIOTECH Natamycin Sales by Application in 2024
5.5.7 AMTECH BIOTECH Natamycin Sales by Geographic Area in 2024
5.5.8 AMTECH BIOTECH Recent Developments
5.6 Silver-Elephant
5.6.1 Silver-Elephant Company Information
5.6.2 Silver-Elephant Description, Business Overview
5.6.3 Silver-Elephant Natamycin Products Offered
5.6.4 Silver-Elephant Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Silver-Elephant Natamycin Sales by Product in 2024
5.6.6 Silver-Elephant Natamycin Sales by Application in 2024
5.6.7 Silver-Elephant Natamycin Sales by Geographic Area in 2024
5.6.8 Silver-Elephant Recent Developments
5.7 Lanzhou Weiri
5.7.1 Lanzhou Weiri Company Information
5.7.2 Lanzhou Weiri Description, Business Overview
5.7.3 Lanzhou Weiri Natamycin Products Offered
5.7.4 Lanzhou Weiri Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Lanzhou Weiri Natamycin Sales by Product in 2024
5.7.6 Lanzhou Weiri Natamycin Sales by Application in 2024
5.7.7 Lanzhou Weiri Natamycin Sales by Geographic Area in 2024
5.7.8 Lanzhou Weiri Recent Developments
5.8 Langfang Meihua
5.8.1 Langfang Meihua Company Information
5.8.2 Langfang Meihua Description, Business Overview
5.8.3 Langfang Meihua Natamycin Products Offered
5.8.4 Langfang Meihua Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Langfang Meihua Natamycin Sales by Product in 2024
5.8.6 Langfang Meihua Natamycin Sales by Application in 2024
5.8.7 Langfang Meihua Natamycin Sales by Geographic Area in 2024
5.8.8 Langfang Meihua Recent Developments
5.9 Zhengzhou New Frey
5.9.1 Zhengzhou New Frey Company Information
5.9.2 Zhengzhou New Frey Description, Business Overview
5.9.3 Zhengzhou New Frey Natamycin Products Offered
5.9.4 Zhengzhou New Frey Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Zhengzhou New Frey Natamycin Sales by Product in 2024
5.9.6 Zhengzhou New Frey Natamycin Sales by Application in 2024
5.9.7 Zhengzhou New Frey Natamycin Sales by Geographic Area in 2024
5.9.8 Zhengzhou New Frey Recent Developments
5.10 Chihon
5.10.1 Chihon Company Information
5.10.2 Chihon Description, Business Overview
5.10.3 Chihon Natamycin Products Offered
5.10.4 Chihon Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Chihon Natamycin Sales by Product in 2024
5.10.6 Chihon Natamycin Sales by Application in 2024
5.10.7 Chihon Natamycin Sales by Geographic Area in 2024
5.10.8 Chihon Recent Developments
5.11 Jiaozuo Joincare
5.11.1 Jiaozuo Joincare Company Information
5.11.2 Jiaozuo Joincare Description, Business Overview
5.11.3 Jiaozuo Joincare Natamycin Products Offered
5.11.4 Jiaozuo Joincare Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Jiaozuo Joincare Natamycin Sales by Product in 2024
5.11.6 Jiaozuo Joincare Natamycin Sales by Application in 2024
5.11.7 Jiaozuo Joincare Natamycin Sales by Geographic Area in 2024
5.11.8 Jiaozuo Joincare Recent Developments
5.12 Beijing Oriental Rada
5.12.1 Beijing Oriental Rada Company Information
5.12.2 Beijing Oriental Rada Description, Business Overview
5.12.3 Beijing Oriental Rada Natamycin Products Offered
5.12.4 Beijing Oriental Rada Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Beijing Oriental Rada Natamycin Sales by Product in 2024
5.12.6 Beijing Oriental Rada Natamycin Sales by Application in 2024
5.12.7 Beijing Oriental Rada Natamycin Sales by Geographic Area in 2024
5.12.8 Beijing Oriental Rada Recent Developments
5.13 Pucheng Lifecome
5.13.1 Pucheng Lifecome Company Information
5.13.2 Pucheng Lifecome Description, Business Overview
5.13.3 Pucheng Lifecome Natamycin Products Offered
5.13.4 Pucheng Lifecome Natamycin Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Pucheng Lifecome Natamycin Sales by Product in 2024
5.13.6 Pucheng Lifecome Natamycin Sales by Application in 2024
5.13.7 Pucheng Lifecome Natamycin Sales by Geographic Area in 2024
5.13.8 Pucheng Lifecome Recent Developments
6 North America
6.1 North America Natamycin Market Size YoY Growth 2020-2031
6.2 North America Natamycin Market Facts & Figures by Country
6.2.1 North America Natamycin Sales by Country (2020-2031)
6.2.2 North America Natamycin Revenue by Country (2020-2031)
6.3 North America Natamycin Sales by Type (2020-2025)
6.4 North America Natamycin Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Natamycin Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Natamycin Market Facts & Figures by Region
7.2.1 Asia-Pacific Natamycin Sales by Region (2020-2031)
7.2.2 Asia-Pacific Natamycin Revenue by Region (2020-2031)
7.3 Asia-Pacific Natamycin Sales by Type (2020-2025)
7.4 Asia-Pacific Natamycin Sales by Application (2020-2025)
8 Europe
8.1 Europe Natamycin Market Size YoY Growth 2020-2031
8.2 Europe Natamycin Market Facts & Figures by Country
8.2.1 Europe Natamycin Sales by Country (2020-2031)
8.2.2 Europe Natamycin Revenue by Country (2020-2031)
8.3 Europe Natamycin Sales by Type (2020-2025)
8.4 Europe Natamycin Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Natamycin Market Size YoY Growth 2020-2031
9.2 Latin America Natamycin Market Facts & Figures by Country
9.2.1 Latin America Natamycin Sales by Country (2020-2031)
9.2.2 Latin America Natamycin Revenue by Country (2020-2031)
9.3 Latin America Natamycin Sales by Type (2020-2025)
9.4 Latin America Natamycin Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Natamycin Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Natamycin Market Facts & Figures by Country
10.2.1 Middle East and Africa Natamycin Sales by Country (2020-2031)
10.2.2 Middle East and Africa Natamycin Revenue by Country (2020-2031)
10.3 Middle East and Africa Natamycin Sales by Type (2020-2025)
10.4 Middle East and Africa Natamycin Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Natamycin Supply Chain Analysis
11.2 Natamycin Key Raw Materials and Upstream Suppliers
11.3 Natamycin Clients Analysis
11.4 Natamycin Sales Channel and Sales Model Analysis
11.4.1 Natamycin Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Natamycin Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Natamycin Distributors
12 Natamycin Market Dynamics
12.1 Natamycin Industry Trends
12.2 Natamycin Market Drivers
12.3 Natamycin Market Challenges
12.4 Natamycin Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Danisco
DSM
VGP
Handary
Amtech Biotech
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
List of Tables
 Table 1. Global Natamycin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Natamycin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Natamycin Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Natamycin Sales by Region (2020-2025) & (MT)
 Table 5. Global Natamycin Sales Forecast by Region (2026-2031) & (MT)
 Table 6. Global Natamycin Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Natamycin Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Natamycin Sales Volume by Type (2020-2025) & (MT)
 Table 9. Global Natamycin Sales Volume by Type (2026-2031) & (MT)
 Table 10. Global Natamycin Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Natamycin Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Natamycin Sales Volume by Application (2020-2025) & (MT)
 Table 13. Global Natamycin Sales Volume by Application (2026-2031) & (MT)
 Table 14. Global Natamycin Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Natamycin Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Natamycin Sales by Manufacturer (2020-2025) & (MT)
 Table 17. Global Natamycin Sales Share by Manufacturer (2020-2025)
 Table 18. Natamycin Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Natamycin Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Natamycin Price (2020-2025) & (USD/MT)
 Table 21. Ranking of Global Top Natamycin Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Natamycin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Natamycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natamycin as of 2024)
 Table 24. Natamycin Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Natamycin Market
 Table 26. Manufacturers Natamycin Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Danisco Company Information
 Table 29. Danisco Description and Business Overview
 Table 30. Danisco Natamycin Product
 Table 31. Danisco Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 32. Danisco Sales Proportion of Natamycin by Product in 2024
 Table 33. Danisco Sales Proportion of Natamycin by Application in 2024
 Table 34. Danisco Sales Proportion of Natamycin by Geographic Area in 2024
 Table 35. Danisco Recent Developments
 Table 36. DSM Company Information
 Table 37. DSM Description and Business Overview
 Table 38. DSM Natamycin Product
 Table 39. DSM Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 40. DSM Sales Proportion of Natamycin by Product in 2024
 Table 41. DSM Sales Proportion of Natamycin by Application in 2024
 Table 42. DSM Sales Proportion of Natamycin by Geographic Area in 2024
 Table 43. DSM Recent Developments
 Table 44. VGP Company Information
 Table 45. VGP Description and Business Overview
 Table 46. VGP Natamycin Product
 Table 47. VGP Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 48. VGP Sales Proportion of Natamycin by Product in 2024
 Table 49. VGP Sales Proportion of Natamycin by Application in 2024
 Table 50. VGP Sales Proportion of Natamycin by Geographic Area in 2024
 Table 51. VGP Recent Developments
 Table 52. Handary Company Information
 Table 53. Handary Description and Business Overview
 Table 54. Handary Natamycin Product
 Table 55. Handary Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 56. Handary Sales Proportion of Natamycin by Product in 2024
 Table 57. Handary Sales Proportion of Natamycin by Application in 2024
 Table 58. Handary Sales Proportion of Natamycin by Geographic Area in 2024
 Table 59. Handary Recent Developments
 Table 60. AMTECH BIOTECH Company Information
 Table 61. AMTECH BIOTECH Description and Business Overview
 Table 62. AMTECH BIOTECH Natamycin Product
 Table 63. AMTECH BIOTECH Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 64. AMTECH BIOTECH Sales Proportion of Natamycin by Product in 2024
 Table 65. AMTECH BIOTECH Sales Proportion of Natamycin by Application in 2024
 Table 66. AMTECH BIOTECH Sales Proportion of Natamycin by Geographic Area in 2024
 Table 67. AMTECH BIOTECH Recent Developments
 Table 68. Silver-Elephant Company Information
 Table 69. Silver-Elephant Description and Business Overview
 Table 70. Silver-Elephant Natamycin Product
 Table 71. Silver-Elephant Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 72. Silver-Elephant Sales Proportion of Natamycin by Product in 2024
 Table 73. Silver-Elephant Sales Proportion of Natamycin by Application in 2024
 Table 74. Silver-Elephant Sales Proportion of Natamycin by Geographic Area in 2024
 Table 75. Silver-Elephant Recent Developments
 Table 76. Lanzhou Weiri Company Information
 Table 77. Lanzhou Weiri Description and Business Overview
 Table 78. Lanzhou Weiri Natamycin Product
 Table 79. Lanzhou Weiri Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 80. Lanzhou Weiri Sales Proportion of Natamycin by Product in 2024
 Table 81. Lanzhou Weiri Sales Proportion of Natamycin by Application in 2024
 Table 82. Lanzhou Weiri Sales Proportion of Natamycin by Geographic Area in 2024
 Table 83. Lanzhou Weiri Recent Developments
 Table 84. Langfang Meihua Company Information
 Table 85. Langfang Meihua Description and Business Overview
 Table 86. Langfang Meihua Natamycin Product
 Table 87. Langfang Meihua Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Langfang Meihua Sales Proportion of Natamycin by Product in 2024
 Table 89. Langfang Meihua Sales Proportion of Natamycin by Application in 2024
 Table 90. Langfang Meihua Sales Proportion of Natamycin by Geographic Area in 2024
 Table 91. Langfang Meihua Recent Developments
 Table 92. Zhengzhou New Frey Company Information
 Table 93. Zhengzhou New Frey Description and Business Overview
 Table 94. Zhengzhou New Frey Natamycin Product
 Table 95. Zhengzhou New Frey Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 96. Zhengzhou New Frey Sales Proportion of Natamycin by Product in 2024
 Table 97. Zhengzhou New Frey Sales Proportion of Natamycin by Application in 2024
 Table 98. Zhengzhou New Frey Sales Proportion of Natamycin by Geographic Area in 2024
 Table 99. Zhengzhou New Frey Recent Developments
 Table 100. Chihon Company Information
 Table 101. Chihon Description and Business Overview
 Table 102. Chihon Natamycin Product
 Table 103. Chihon Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 104. Chihon Sales Proportion of Natamycin by Product in 2024
 Table 105. Chihon Sales Proportion of Natamycin by Application in 2024
 Table 106. Chihon Sales Proportion of Natamycin by Geographic Area in 2024
 Table 107. Chihon Recent Developments
 Table 108. Jiaozuo Joincare Company Information
 Table 109. Jiaozuo Joincare Description and Business Overview
 Table 110. Jiaozuo Joincare Natamycin Product
 Table 111. Jiaozuo Joincare Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 112. Jiaozuo Joincare Sales Proportion of Natamycin by Product in 2024
 Table 113. Jiaozuo Joincare Sales Proportion of Natamycin by Application in 2024
 Table 114. Jiaozuo Joincare Sales Proportion of Natamycin by Geographic Area in 2024
 Table 115. Jiaozuo Joincare Recent Developments
 Table 116. Beijing Oriental Rada Company Information
 Table 117. Beijing Oriental Rada Description and Business Overview
 Table 118. Beijing Oriental Rada Natamycin Product
 Table 119. Beijing Oriental Rada Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 120. Beijing Oriental Rada Sales Proportion of Natamycin by Product in 2024
 Table 121. Beijing Oriental Rada Sales Proportion of Natamycin by Application in 2024
 Table 122. Beijing Oriental Rada Sales Proportion of Natamycin by Geographic Area in 2024
 Table 123. Beijing Oriental Rada Recent Developments
 Table 124. Pucheng Lifecome Company Information
 Table 125. Pucheng Lifecome Description and Business Overview
 Table 126. Pucheng Lifecome Natamycin Product
 Table 127. Pucheng Lifecome Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. Pucheng Lifecome Sales Proportion of Natamycin by Product in 2024
 Table 129. Pucheng Lifecome Sales Proportion of Natamycin by Application in 2024
 Table 130. Pucheng Lifecome Sales Proportion of Natamycin by Geographic Area in 2024
 Table 131. Pucheng Lifecome Recent Developments
 Table 132. North America Natamycin Sales by Country (2020-2025) & (MT)
 Table 133. North America Natamycin Sales by Country (2026-2031) & (MT)
 Table 134. North America Natamycin Revenue by Country (2020-2025) & (US$ Million)
 Table 135. North America Natamycin Revenue by Country (2026-2031) & (US$ Million)
 Table 136. North America Natamycin Sales by Type (2020-2025) & (MT)
 Table 137. North America Natamycin Sales by Application (2020-2025) & (MT)
 Table 138. Asia-Pacific Natamycin Sales by Region (2020-2025) & (MT)
 Table 139. Asia-Pacific Natamycin Sales by Region (2026-2031) & (MT)
 Table 140. Asia-Pacific Natamycin Revenue by Region (2020-2025) & (US$ Million)
 Table 141. Asia-Pacific Natamycin Revenue by Region (2026-2031) & (US$ Million)
 Table 142. Asia-Pacific Natamycin Sales by Type (2020-2025) & (MT)
 Table 143. Asia-Pacific Natamycin Sales by Application (2020-2025) & (MT)
 Table 144. Europe Natamycin Sales by Country (2020-2025) & (MT)
 Table 145. Europe Natamycin Sales by Country (2026-2031) & (MT)
 Table 146. Europe Natamycin Revenue by Country (2020-2025) & (US$ Million)
 Table 147. Europe Natamycin Revenue by Country (2026-2031) & (US$ Million)
 Table 148. Europe Natamycin Sales by Type (2020-2025) & (MT)
 Table 149. Europe Natamycin Sales by Application (2020-2025) & (MT)
 Table 150. Latin America Natamycin Sales by Country (2020-2025) & (MT)
 Table 151. Latin America Natamycin Sales by Country (2026-2031) & (MT)
 Table 152. Latin America Natamycin Revenue by Country (2020-2025) & (US$ Million)
 Table 153. Latin America Natamycin Revenue by Country (2026-2031) & (US$ Million)
 Table 154. Latin America Natamycin Sales by Type (2020-2025) & (MT)
 Table 155. Latin America Natamycin Sales by Application (2020-2025) & (MT)
 Table 156. Middle East and Africa Natamycin Sales by Country (2020-2025) & (MT)
 Table 157. Middle East and Africa Natamycin Sales by Country (2026-2031) & (MT)
 Table 158. Middle East and Africa Natamycin Revenue by Country (2020-2025) & (US$ Million)
 Table 159. Middle East and Africa Natamycin Revenue by Country (2026-2031) & (US$ Million)
 Table 160. Middle East and Africa Natamycin Sales by Type (2020-2025) & (MT)
 Table 161. Middle East and Africa Natamycin Sales by Application (2020-2025) & (MT)
 Table 162. Natamycin Key Raw Materials, Industry Status and Trend
 Table 163. Natamycin Key Raw Materials and Upstream Suppliers
 Table 164. Natamycin Clients Status and Trend
 Table 165. Natamycin Typical Clients
 Table 166. Natamycin Distributors
 Table 167. Natamycin Market Trends
 Table 168. Natamycin Market Drivers
 Table 169. Natamycin Market Challenges
 Table 170. Natamycin Market Restraints
 Table 171. Research Programs/Design for This Report
 Table 172. Key Data Information from Secondary Sources
 Table 173. Key Data Information from Primary Sources
 Table 174. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Natamycin Product Picture
 Figure 2. Global Natamycin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Natamycin Sales Market Share by Type in 2024 & 2031
 Figure 4. Glucose-based Product Picture
 Figure 5. Lactose-based Product Picture
 Figure 6. Sodium chloride-based Product Picture
 Figure 7. Global Natamycin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Natamycin Sales Market Share by Application in 2024 & 2031
 Figure 9. Food
 Figure 10. Medical
 Figure 11. Others
 Figure 12. Natamycin Report Years Considered
 Figure 13. Global Natamycin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Natamycin Market Size 2020-2031 (US$ Million)
 Figure 15. Global Natamycin Sales 2020-2031 (MT)
 Figure 16. Global Natamycin Sales Market Share Forecast by Region (2020-2031)
 Figure 17. Global Natamycin Revenue Market Share by Region (2020-2031)
 Figure 18. Global Natamycin Sales Market Share Forecast by Type (2020-2031)
 Figure 19. Global Natamycin Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Natamycin Average Selling Price (ASP) by Type (2020-2025) & (USD/MT)
 Figure 21. Global Natamycin Sales Market Share Forecast by Application (2020-2031)
 Figure 22. Global Natamycin Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Natamycin Average Selling Price (ASP) by Application (2020-2025) & (USD/MT)
 Figure 24. Glucose-based of Natamycin Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Lactose-based of Natamycin Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Sodium chloride-based of Natamycin Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Global Natamycin Sales Share by Manufacturer in 2024
 Figure 28. Natamycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. Glucose-based Market Sales Proportion by Manufacturer in 2024
 Figure 30. Lactose-based Market Sales Proportion by Manufacturer in 2024
 Figure 31. Sodium chloride-based Market Sales Proportion by Manufacturer in 2024
 Figure 32. North America Natamycin Revenue 2020-2031 (US$ Million)
 Figure 33. North America Natamycin Sales Market Share by Type (2020-2025)
 Figure 34. North America Natamycin Sales Market Share by Application (2020-2025)
 Figure 35. Asia-Pacific Natamycin Revenue 2020-2031 (US$ Million)
 Figure 36. Asia-Pacific Natamycin Sales Market Share by Region (2020-2031)
 Figure 37. Asia-Pacific Natamycin Revenue Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Natamycin Sales Market Share by Type (2020-2025)
 Figure 39. Asia-Pacific Natamycin Sales Market Share by Application (2020-2025)
 Figure 40. Europe Natamycin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Europe Natamycin Sales Market Share by Country (2020-2031)
 Figure 42. Europe Natamycin Revenue Market Share by Country (2020-2031)
 Figure 43. Europe Natamycin Sales Market Share by Type (2020-2025)
 Figure 44. Europe Natamycin Sales Market Share by Application (2020-2025)
 Figure 45. Latin America Natamycin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Latin America Natamycin Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Natamycin Revenue Market Share by Country (2020-2025)
 Figure 48. Latin America Natamycin Sales Market Share by Type (2020-2025)
 Figure 49. Latin America Natamycin Sales Market Share by Application (2020-2025)
 Figure 50. Middle East and Africa Natamycin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 51. Middle East and Africa Natamycin Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Natamycin Revenue Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Natamycin Sales Market Share by Type (2020-2025)
 Figure 54. Middle East and Africa Natamycin Sales Market Share by Application (2020-2025)
 Figure 55. Natamycin Supply Chain (Upstream and Downstream Market)
 Figure 56. Global Production Market Share of Natamycin Raw Materials by Region in 2024
 Figure 57. Natamycin Distribution Channels
 Figure 58. Global Natamycin Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 59. Global Natamycin Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global High Purity Natamycin Powder Market Research Report 2024
Food Grade Natamycin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Natto Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Validamycin Market Research Report 2024
Global Neomycin Sulfate API Market Research Report 2024
Global Natamycin Eye Drop Market Research Report 2025
Natto Fermentation Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hygromycin B Market Research Report 2024
Global Desmethylicaritin Market Research Report 2024
Nisin for Food Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hygromycin B Solution Market Research Report 2024
Global Penicillin Streptomycin Gentamicin Solution Market Research Report 2025
Global White Dextrin Market Insights Forecast to 2030
Global Natto Market Research Report 2025
Global Aminoglycosides Antibiotics Market Research Report 2024
Global Lincomycin Antibiotics Market Research Report 2024
Global Virginiamycin Market Research Report 2024
Global Yellow and White Dextrin Powder Market Insights Forecast to 2030
Global Maduramicin Ammonium Premix Market Research Report 2024
Fosfomycin Trometamol Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions